Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

E. Negredo; L. Cruz; R. Paredes; L. Ruiz; C.R. Fumaz; A. Bonjoch; S. Gel; M. Tuldrà; M. Balagué; S. Johnston; A. Arnó; A. Jou; C. Tural; G. Sirera; J. Romeu; B. Clotet

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

E. Negredo, L. Cruz, R. Paredes, L. Ruiz, C.R. Fumaz, A. Bonjoch, S. Gel, M. Tuldrà, M. Balagué, S. Johnston, A. Arnó, A. Jou, C. Tural, G. Sirera, J. Romeu, B. Clotet

Department of Medicine

Research output: Contribution to journal › Article › Research

157 Citations (Scopus)

Original language	English
Pages (from-to)	504-510
Journal	Clin. Infect. Dis.
Volume	34
Issue number	4
Publication status	Published - 1 Jan 2002

Cite this

Negredo, E., Cruz, L., Paredes, R., Ruiz, L., Fumaz, C. R., Bonjoch, A., Gel, S., Tuldrà, M., Balagué, M., Johnston, S., Arnó, A., Jou, A., Tural, C., Sirera, G., Romeu, J., & Clotet, B. (2002). Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. Clin. Infect. Dis., 34(4), 504-510.

Negredo, E. ; Cruz, L. ; Paredes, R. ; Ruiz, L. ; Fumaz, C.R. ; Bonjoch, A. ; Gel, S. ; Tuldrà, M. ; Balagué, M. ; Johnston, S. ; Arnó, A. ; Jou, A. ; Tural, C. ; Sirera, G. ; Romeu, J. ; Clotet, B. / Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. In: Clin. Infect. Dis. 2002 ; Vol. 34, No. 4. pp. 504-510.

@article{97e4ddc907c64ab1b105e617f13e245e,

title = "Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression",

author = "E. Negredo and L. Cruz and R. Paredes and L. Ruiz and C.R. Fumaz and A. Bonjoch and S. Gel and M. Tuldr{\`a} and M. Balagu{\'e} and S. Johnston and A. Arn{\'o} and A. Jou and C. Tural and G. Sirera and J. Romeu and B. Clotet",

year = "2002",

month = jan,

day = "1",

language = "English",

volume = "34",

pages = "504--510",

number = "4",

}

Negredo, E, Cruz, L, Paredes, R, Ruiz, L, Fumaz, CR, Bonjoch, A, Gel, S, Tuldrà, M, Balagué, M, Johnston, S, Arnó, A, Jou, A, Tural, C, Sirera, G, Romeu, J & Clotet, B 2002, 'Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression', Clin. Infect. Dis., vol. 34, no. 4, pp. 504-510.

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. / Negredo, E.; Cruz, L.; Paredes, R.; Ruiz, L.; Fumaz, C.R.; Bonjoch, A.; Gel, S.; Tuldrà, M.; Balagué, M.; Johnston, S.; Arnó, A.; Jou, A.; Tural, C.; Sirera, G.; Romeu, J.; Clotet, B.

In: Clin. Infect. Dis., Vol. 34, No. 4, 01.01.2002, p. 504-510.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

AU - Negredo, E.

AU - Cruz, L.

AU - Paredes, R.

AU - Ruiz, L.

AU - Fumaz, C.R.

AU - Bonjoch, A.

AU - Gel, S.

AU - Tuldrà, M.

AU - Balagué, M.

AU - Johnston, S.

AU - Arnó, A.

AU - Jou, A.

AU - Tural, C.

AU - Sirera, G.

AU - Romeu, J.

AU - Clotet, B.

PY - 2002/1/1

Y1 - 2002/1/1

M3 - Article

VL - 34

SP - 504

EP - 510

IS - 4

ER -